Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02420717
Title Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

B-cell acute lymphoblastic leukemia

Therapies

Ruxolitinib

Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine Sulfate

Dasatinib

Mercaptopurine + Methotrexate + Prednisone + Vincristine Sulfate

Cytarabine + Leucovorin + Methotrexate

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.